Dexmedetomidine-Ketamine Infusion in Breast Surgeries

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

March 20, 2024

Study Completion Date

March 20, 2024

Conditions
Total Intravenous Anesthesia
Interventions
DRUG

Placebos

The patients in this group will be connected to the syringe pump that contain normal saline with starting infusion at a rate of 0.1 ml/kg/hr till the end of the surgery.

DRUG

Dexmedetomidine +Ketamine

The patients in this group will be connected to the syringe pump that contain mixture of dexmedetomidine and ketamine with starting infusion at a rate of 0.1 ml/kg/hr till the end of the surgery. The solution will contain 2 ug dexmedetomidine/ml and 1 mg ketamine/ml.

Trial Locations (1)

31511

Tanta University hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04048226 - Dexmedetomidine-Ketamine Infusion in Breast Surgeries | Biotech Hunter | Biotech Hunter